Back
Cogent Biosciences Vs. The Chemours Industry Stock Comparison
Sell
29
COGT
Cogent Biosciences
Last Price:
5.95
Seasonality Move:
100.43%
Buy
60
CC
The Chemours
Last Price:
26.57
Seasonality Move:
7.34%
Sell
29
Cogent Biosciences (COGT)
is a Sell
Is Cogent Biosciences a Buy, Sell or Hold?
- The current Cogent Biosciences [COGT] share price is $6.54. The Score for COGT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- COGT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
The Chemours (CC)
is a Buy
Is The Chemours a Buy, Sell or Hold?
- The current The Chemours [CC] share price is $27.08. The Score for CC is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- CC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
COGT Stock Price Chart
What is Cogent Biosciences's stock price today?
-
The Cogent Biosciences share price today is $6.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COGT is experiencing selling pressure, which indicates risk of future bearish movement.
CC Stock Price Chart
What is The Chemours's stock price today?
-
The The Chemours share price today is $27.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CC is experiencing slight selling pressure.
COGT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 47.39 | Sell |
Chaikin Money Flow: | -1512642 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.32 - 6.92) | Sell |
Bollinger Bands (100): | (5.03 - 7.53) | Buy |
CC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 50.88 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.38 - 28.06) | Sell |
Bollinger Bands (100): | (26.02 - 31.16) | Sell |
COGT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.68 | Sell |
20-day SMA: | 6.7 | Sell |
50-day SMA: | 6.97 | Sell |
200-day SMA: | 8.33 | Sell |
8-day EMA: | 6.72 | Sell |
20-day EMA: | 6.69 | Sell |
50-day EMA: | 6.65 | Sell |
200-day EMA: | 7.92 | Sell |
CC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.43 | Buy |
20-day SMA: | 27.12 | Sell |
50-day SMA: | 26.79 | Buy |
200-day SMA: | 29.57 | Sell |
8-day EMA: | 26.67 | Buy |
20-day EMA: | 26.85 | Buy |
50-day EMA: | 27.26 | Sell |
200-day EMA: | 28.93 | Sell |
Cogent Biosciences Earnings Growth & COGT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and a decrease next year of $0.12 per share.
The Chemours Earnings Growth & CC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.68 per share, and an increase next year of $2.19 per share.
Cogent Biosciences Technical Analysis
Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
The Chemours Technical Analysis
Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |